tradingkey.logo
tradingkey.logo
Search

Catheter Precision Inc

VTAK
Add to Watchlist
0.790USD
-0.085-9.83%
Close 07/02, 13:00ETQuotes delayed by 15 min
2.13MMarket Cap
LossP/E TTM

More Details of Catheter Precision Inc Company

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

Catheter Precision Inc Info

Ticker SymbolVTAK
Company nameCatheter Precision Inc
IPO dateSep 27, 2018
CEOJenkins (David A)
Number of employees22
Security typeOrdinary Share
Fiscal year-endSep 27
Address1670 Highway 160 West
CityFORT MILL
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code29708
Phone19736912000
Websitehttps://www.ramed.com/
Ticker SymbolVTAK
IPO dateSep 27, 2018
CEOJenkins (David A)

Company Executives of Catheter Precision Inc

Name
Name/Position
Position
Shareholding
Change
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
48.49K
+54.05%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
48.49K
+54.05%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Catheter Precision Inc?

The top five shareholders of Catheter Precision Inc are: Mr. David Jenkins

How many institutions hold shares of Catheter Precision Inc (VTAK)?

As of 2026Q1, 28 institutions hold shares of Catheter Precision Inc, with a combined market value of approximately 304.48K, accounting for 11.31% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 230261.00.